Champions Oncology (CSBR) EBITDA Margin Growth (5y) (2015 - 2026)
Powered by 
Analysis
Champions Oncology (CSBR) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 236.00 |
| Jan 31, 2026 | -1,075.00 |
| Oct 31, 2025 | 116.00 |
| Jul 31, 2025 | -402.00 |
| Apr 30, 2025 | 696.00 |
| Jan 31, 2025 | 2,160.00 |
| Oct 31, 2024 | 161.00 |
| Jul 31, 2024 | 1,857.00 |
| Apr 30, 2024 | -43.00 |
| Jan 31, 2024 | -1,569.00 |
| Oct 31, 2023 | -2,100.00 |
| Jul 31, 2023 | -2,804.00 |
| Apr 30, 2023 | -712.00 |
| Jan 31, 2023 | -1,793.00 |
| Oct 31, 2022 | 139.00 |
| Jul 31, 2022 | 1,023.00 |
| Apr 30, 2022 | 6,181.00 |
| Jan 31, 2022 | 4,559.00 |
| Oct 31, 2021 | 1,329.00 |
| Jul 31, 2021 | 6,719.00 |